Jim Nolan has spent decades in the pharmaceutical industry working to find, establish, fund and manage, needed treatments and organizations in a variety of diseases. He has a proven track record in big pharma as well as smaller biotech organizations and has played a leading role in world-wide programs to discover and promote novel therapies, devices and diagnostics for diabetic complications, diabetes, obesity and related disorders. This focus grew to include inflammation, pain, female health, cardiovascular disease, dermatology and cancer. His philosophy in the life science industry is based on one principle: “Great Science is the first priority to success.”